Pediatrics News

  • Alert FDA Clears Long-Acting ADHD Drug Mydayis Mydayis (mixed salts of amphetamine) is formulated to last up to 16 hours and is approved for adults and children aged 13 years and older.
  • EAACI Experts Cautious About Food Diversity to Avert Allergy Despite evidence suggesting that exposure to different food types introduced early in childhood protects against allergic diseases, researchers say it is too early to make recommendations.

Today on Medscape

Top Stories from Across Medicine

Top Medical News from Across Medscape

  • Senate Unveils Bill to Repeal and Replace ACAThe Senate Republican bill, crafted behind closed doors, is a softer version of what the House passed in many ways and a harder version in others.
  • Zika Diagnosis Confirmed by Placental Sample TestingCDC study found that testing for RNA in placental samples can confirm the diagnosis of Zika in cases that are not definitive; appropriate testing and follow-up are still critical.
  • PCMH Implementation Assistance Program Has Mixed ResultsMost federally qualified health centers that got the help achieved level 3 PCMH status, a new study has found. But they also had more ED visits and hospital admissions than a control group.


Business of Medicine

  • The War Over MOC Heats Up In at least 17 states, doctors are battling the American Board of Medical Specialties, hospitals, and insurers in an effort to make maintenance of certification optional. Here's how it's going.
  • A Hospital Gets Sued for Keeping a Patient Alive   Hospital clinicians who don't follow a patient's advance healthcare directive are at risk of being sued.


Advisory Board


Medscape Editor-in-Chief

  • Eric J. Topol, MD Eric J. Topol, MD Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute; Senior Consultant, Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California; Editor-in-Chief, Medscape